All the news Showing 10 of 130 articles from: TreatmentGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Changes to VIREAD (tenofovir DF) labeling for Hepatitis B FDA / 29 July 2013 UK: NICE OKs hep C treatment for children Pharma Times / 24 July 2013 Many people need hepatitis B treatment in the Gambia Liz Highleyman / 17 July 2013 About 8% of people tested through a community-based screening program in the Gambia have hepatitis B, and about 8% of these have advanced liver disease and meet European criteria for antiviral therapy, according ... Asian and Caucasian patients respond similarly to pegylated interferon for chronic hepatitis B Keith Alcorn / 20 May 2013 Some Asian people with chronic hepatitis B treated with pegylated interferon may experience better outcomes on certain measures than Caucasians, though overall response rates are similar, according to a comparative analysis presented at ... Truvada works best for immune-tolerant hepatitis B patients, but do they need treatment? Liz Highleyman / 07 May 2013 A combination of tenofovir and emtricitabine (the drugs in the combination pill Truvada) suppressed hepatitis B virus (HBV) replication more than tenofovir alone over four years for people with inactive or immune-tolerant disease, ... Combination Drugs are the Future of the European Hepatitis B and C Therapeutics Markets, Says Frost & Sullivan Frost & Sullivan press release / 03 May 2013 HIV Drug Combo Shows Promise in Hepatitis B MedPage Today Gastroenterology / 28 April 2013 Long-term tenofovir reduces liver cancer risk in people with hepatitis B Liz Highleyman / 27 April 2013 Long-term treatment with tenofovir (Viread) lowered the risk of developing hepatocellular carcinoma among people with chronic hepatitis B, with a notable divergence from expected rates after about five years, according to a ... Novel Therapeutic Approches to Cure Chronic HBV Infection EASL / 26 April 2013 Arrowhead data demonstrates RNAi candidate ARC-520 silences hepatitis B virus Arrowhead Research Corp press release / 27 February 2013 ← Prev1...910111213Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Transmission and prevention Diagnosis and monitoring Disease course and symptoms Treatment HIV and HBV HCV and HBV Hepatitis delta Living with HBV Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds